Subcutaneous injection of 99mTc-pertechnetate for neonatal thyroid scintigraphy.

Ray K. Bradford, Mark Tulchinsky

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 9-day-old female infant with congenital hypothyroidism presented for thyroid scintigraphy. Multiple attempts including the "intravenous team" failed to establish peripheral access for administration of 99mTc-pertechnetate. We administered 99mTc-pertechnetate subcutaneously into the upper arm. Rapid absorption (85% of the dose in 20 minutes) was documented on dynamic images with physiological uptake, allowing diagnostic thyroid scintigraphy at 35 minutes that revealed ectopic sublingual thyroid. Subcutaneous injection allowed us to avoid traumatic and risky central vascular access procedure. When peripheral intravenous access cannot be obtained, 99mTc-pertechnetate can be administered subcutaneously for diagnostic thyroid scintigraphy, which is particularly useful in neonates.

Original languageEnglish (US)
Pages (from-to)1015-1018
Number of pages4
JournalClinical Nuclear Medicine
Volume38
Issue number12
StatePublished - Jan 1 2013

Fingerprint

Sodium Pertechnetate Tc 99m
Subcutaneous Injections
Radionuclide Imaging
Thyroid Gland
Thyroid Dysgenesis
Congenital Hypothyroidism
Blood Vessels
Arm
Newborn Infant

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

@article{a0ecc74aac2a41d4bf4003e362f742ad,
title = "Subcutaneous injection of 99mTc-pertechnetate for neonatal thyroid scintigraphy.",
abstract = "A 9-day-old female infant with congenital hypothyroidism presented for thyroid scintigraphy. Multiple attempts including the {"}intravenous team{"} failed to establish peripheral access for administration of 99mTc-pertechnetate. We administered 99mTc-pertechnetate subcutaneously into the upper arm. Rapid absorption (85{\%} of the dose in 20 minutes) was documented on dynamic images with physiological uptake, allowing diagnostic thyroid scintigraphy at 35 minutes that revealed ectopic sublingual thyroid. Subcutaneous injection allowed us to avoid traumatic and risky central vascular access procedure. When peripheral intravenous access cannot be obtained, 99mTc-pertechnetate can be administered subcutaneously for diagnostic thyroid scintigraphy, which is particularly useful in neonates.",
author = "Bradford, {Ray K.} and Mark Tulchinsky",
year = "2013",
month = "1",
day = "1",
language = "English (US)",
volume = "38",
pages = "1015--1018",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

Subcutaneous injection of 99mTc-pertechnetate for neonatal thyroid scintigraphy. / Bradford, Ray K.; Tulchinsky, Mark.

In: Clinical Nuclear Medicine, Vol. 38, No. 12, 01.01.2013, p. 1015-1018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Subcutaneous injection of 99mTc-pertechnetate for neonatal thyroid scintigraphy.

AU - Bradford, Ray K.

AU - Tulchinsky, Mark

PY - 2013/1/1

Y1 - 2013/1/1

N2 - A 9-day-old female infant with congenital hypothyroidism presented for thyroid scintigraphy. Multiple attempts including the "intravenous team" failed to establish peripheral access for administration of 99mTc-pertechnetate. We administered 99mTc-pertechnetate subcutaneously into the upper arm. Rapid absorption (85% of the dose in 20 minutes) was documented on dynamic images with physiological uptake, allowing diagnostic thyroid scintigraphy at 35 minutes that revealed ectopic sublingual thyroid. Subcutaneous injection allowed us to avoid traumatic and risky central vascular access procedure. When peripheral intravenous access cannot be obtained, 99mTc-pertechnetate can be administered subcutaneously for diagnostic thyroid scintigraphy, which is particularly useful in neonates.

AB - A 9-day-old female infant with congenital hypothyroidism presented for thyroid scintigraphy. Multiple attempts including the "intravenous team" failed to establish peripheral access for administration of 99mTc-pertechnetate. We administered 99mTc-pertechnetate subcutaneously into the upper arm. Rapid absorption (85% of the dose in 20 minutes) was documented on dynamic images with physiological uptake, allowing diagnostic thyroid scintigraphy at 35 minutes that revealed ectopic sublingual thyroid. Subcutaneous injection allowed us to avoid traumatic and risky central vascular access procedure. When peripheral intravenous access cannot be obtained, 99mTc-pertechnetate can be administered subcutaneously for diagnostic thyroid scintigraphy, which is particularly useful in neonates.

UR - http://www.scopus.com/inward/record.url?scp=85027950234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027950234&partnerID=8YFLogxK

M3 - Article

C2 - 24212447

AN - SCOPUS:85027950234

VL - 38

SP - 1015

EP - 1018

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 12

ER -